Top Immunoassay Companies

Global Immunoassay Market size was valued at USD 35.12 Billion in 2024 and is poised to grow from USD 37.08 Billion in 2025 to USD 57.3 Billion by 2033, growing at a CAGR of 5.59% during the forecast period (2026–2033).

Key vendors in the Immunoassay Market include Abbott Laboratories, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Siemens Healthineers, Danaher Corporation, Becton, Dickinson and Company, Bio-Rad Laboratories, QIAGEN, Sysmex, Merck KGaA, DiaSorin, bioMérieux, QuidelOrtho, Agilent Technologies, Hologic, PerkinElmer, Luminex, Autobio Diagnostics, Beckman Coulter, and Randox Laboratories.

Mounting funding from governments and private organizations for healthcare, diagnostic, and therapeutic research is driving the Immunoassay Market. These investments support the development of advanced immunoassay solutions and improve diagnostic capabilities for chronic and infectious diseases.

The key market trend in the Immunoassay Market is the increasing adoption of automated and high-throughput immunoassay systems, enabling faster testing, improved accuracy, standardized workflows, and efficient processing of growing diagnostic volumes across clinical laboratories.

North America accounted for the largest share, supported by advanced healthcare infrastructure, substantial R&D investments, sophisticated diagnostic laboratories, and favorable regulatory conditions that encourage adoption of immunoassay technologies.